A5074900786- Cardiac Valve Diseases and Treatments
- Atrial Fibrillation Management and Outcomes
- COVID-19 and Mental Health
- Antiplatelet Therapy and Cardiovascular Diseases
- Streptococcal Infections and Treatments
- Long-Term Effects of COVID-19
- Coronary Interventions and Diagnostics
- Cardiac Structural Anomalies and Repair
- Lysosomal Storage Disorders Research
- Infective Endocarditis Diagnosis and Management
- Cardiovascular Issues in Pregnancy
Pusan National University Yangsan Hospital
2018-2025
Naju National Hospital
2023
Abstract Objectives Although it is recommended to close the zone of apposition (ZoA) as part repair atrioventricular septal defect (AVSD), had often been left untouched or significant mitral regurgitation (MR) ensued. Adult patients with previously incompletely closed open ZoA have more retracted and thickened edges due long standing MR. Combined annular dilatation, these factors aggravate MR consequently complicate surgical eventually leading valve replacement (MVR). In an effort overcome...
Abstract Backgrounds and Objectives Recognizing the natural progression of aortic valve (AV) disease is helpful in planning intervention significant rheumatic mitral (MV) accompanying AV disease. We aimed to investigate long-term course need for surgery patients with who underwent MV intervention. Methods retrospectively investigated changes following a single tertiary center. A total 890 MS or regurgitation (MR) without concurrent were initially screened eligibility. Among them, 76 met...
Abstract Background/Introduction High thrombotic risk (HTR) features are associated with higher ischemic rate, which may be mitigated by potent antiplatelet therapy. However, concomitant high bleeding (HBR) present, making it unclear whether the intensity of therapy should prioritized. Purpose This study investigated prognostic implications HTR and HBR strata according to (indicated platelet reactivity) after coronary stenting. Methods was defined as having at least one three factors: 1)...
Seoung-Kyun Lee, MD, Bo-Hyun Yoon, PhD, Kyungmin Kim, Ha-Ran Jung, Hangoeunbi Kang, Yuran Jeong, Hyunju Yun, Jye-Heon Song, Young-Hwa Sea, Suhee Park, MD. Mood Emot 2023;21:51-60. https://doi.org/10.35986/me.2023.21.3.51
Abstract Background Fabry disease (FD) is X-linked genetic disorder caused by the deficiency or absent activity of lysosomal α- galactosidase. When heart involved, progressive left ventricular hypertrophy (LVH) key feature. Although, LVH not present in all subjects, some them progress with despite enzyme replacement therapy (ERT). The study aimed to evaluate characteristics patient FD without overt LVH, but progresses their mass index (LVMI). Method : This includes subjects carrying...